July 2024 – COA Patient Advocacy Network News Bulletin
Upcoming Advocacy Chats - Educational Conversations on Cancer Advocacy and Policy .....
Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting
My husband’s cancer came back this summer after not being evident for almost two years.
Computer Model May Help Predict Neuropathy in Breast Cancer Survivors
A new tool may be able to predict which women with breast cancer are more likely to experience nerve damage from taxane treatments, according to a Swedish study from Nature Precision Oncology.
Cancer-related suicides decline sharply since 2013
The rate of cancer-related suicides in the U.S. declined considerably in the past few decades, results of a population-based retrospective study published in Translational Psychiatry showed.
6 ways your primary care doctor can help you prevent cancer
When it comes to spotting — and even stopping — cancer, your primary care physician (PCP) plays a critical role.
New Study Reveals 40% of US Cancer Cases, Nearly Half of Deaths Linked to Modifiable Risk Factors
A new study finds 4 in 10 cancer cases and about one-half of cancer deaths in adults aged 30 years and older may be attributed to modifiable risk factors, such as cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.1
The real reason drug costs are so high in America
Earlier this month, President Biden and Sen. Bernie Sanders (I-Vt.) published an oped about “the outrageous prices that the pharmaceutical industry charges the American people for prescription drugs.”
Out-of-pocket medical costs are substantial and rising for privately insured men with abnormal prostate cancer screening results who require further diagnostic testing
The findings align with a recent American Cancer Society statement urging payers to eliminate costs that may keep patients from undergoing diagnostic tests following prostate cancer screening.
Medicare drug pricing rules will delay access to promising therapies
Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act.
Alcohol is driving a half-dozen types of cancer in the U.S., study finds
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives a clearer sense of just how many cancer cases and deaths may be driven by drinking.
